Cite
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.
MLA
Chan, Keith Syson, et al. “Identification, Molecular Characterization, Clinical Prognosis, and Therapeutic Targeting of Human Bladder Tumor-Initiating Cells.” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, Aug. 2009, pp. 14016–21. EBSCOhost, https://doi.org/10.1073/pnas.0906549106.
APA
Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti Jr., J., Chang, H. Y., van de Rijn, M., Shortliffe, L., & Weissman, I. L. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America, 106(33), 14016–14021. https://doi.org/10.1073/pnas.0906549106
Chicago
Chan, Keith Syson, Inigo Espinosa, Mark Chao, David Wong, Laurie Ailles, Max Diehn, Harcharan Gill, et al. 2009. “Identification, Molecular Characterization, Clinical Prognosis, and Therapeutic Targeting of Human Bladder Tumor-Initiating Cells.” Proceedings of the National Academy of Sciences of the United States of America 106 (33): 14016–21. doi:10.1073/pnas.0906549106.